Kinetics of the dimerization of retroviral proteases: The "fireman's grip" and dimerization

Protein Science

Volumn 12, Issue 10, 2003, Pages 2173-2182

  Ingr, Marek ^a,b   Uhlíková, Tat'Ána ^a   Strisovsky, Kvido ^a,b   Majerová, Eva ^c   Konvalinka, Jan ^a,b  

^a INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c SAIC FREDERICK INC   (United States)

Author keywords

Dimerization; Fireman's grip; Fluorescence; HIV protease; Kinetic assay; Pressure; Retroviral protease

Indexed keywords

ASPARTIC ACID; ASPARTIC PROTEINASE; GLYCINE; HYDROXYL GROUP; PROTEINASE; SERINE; THREONINE;

ARTICLE; AVIAN LEUKOSIS ONCOVIRUS; CATALYSIS; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DIMERIZATION; DISSOCIATION; ENZYME ACTIVE SITE; HYDROGEN BOND; KINETICS; MOLECULAR STABILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN STABILITY; RETROVIRUS; THERMODYNAMICS;

ALGORITHMS; ANIMALS; ASPARTIC ENDOPEPTIDASES; BINDING SITES; DIMERIZATION; ENZYME STABILITY; FLUORESCENT DYES; HIV PROTEASE; HUMANS; HYDROGEN BONDING; KINETICS; MODELS, MOLECULAR; POINT MUTATION; RECOMBINANT PROTEINS; RETROVIRIDAE PROTEINS; SERINE; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY; THREONINE;

AVES; AVIAN LEUKOSIS VIRUS; ONCOVIRINAE; UNIDENTIFIED RETROVIRUS;

EID: 0141720374     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.03171903     Document Type: Article

References (44)

1. Arad, G., Chorev, M., Shtorch, A., Goldblum, A., and Kotler, M. 1995. Point mutation in avian sarcoma leukaemia virus protease which increases its activity but impairs infectious virus production. J. Gen. Virol. Virol 76: 1917-1925.
2. Burstein, H., Bizub, D., and Skalka, A.M. 1991. Assembly and processing of avian retroviral Gag polyproteins containing linked protease dimers. J. Virol. 65: 6165-6172.
3. Cheng, Y.S., Yin, F.H., Foundling, S., Blomstrom, D., and Kettner, C.A. 1990. Stability and activity of human immunodeficiency virus protease: Comparison of the natural dimer with a homologous, single-chain tethered dimer. Proc. Natl. Acad. Sci 87: 9660-9664.
4. Darke, P.L. 1994. Stability of dimeric retroviral proteases. Methods Enzymol. 241: 104-127.
5. Darke, P.L., Jordan, S.P., Hall, D.L., Zugay, J.A., Shafer, J.A., and Kuo, L.C. 1994. Dissociation and association of the HIV-1 protease dimer subunits: Equilibria and rates. Biochemistry 33: 98-105.
6. Dunbrack Jr., R.L. and Cohen, F.E. 1997. Bayesian statistical analysis of protein side-chain rotamer preferences. Protein Sci. 6: 1661-1681.
7. Dunbrack Jr., R.L. and Karplus, M. 1993. Backbone-dependent rotamer library for proteins: Application to side-chain prediction. J. Mol. Biol. 230: 543-574.
8. Dunn, B.M. 1998. Human immunodeficiency virus 1 retropepsin. In Handbook of proteolytic enzymes (eds. A.J. Barret et al.), pp. 919-928. Academic Press, London.
9. Foguel, D., Silva, J.L., and de Prat-Gay, G. 1998. Characterization of a partially folded monomer of the DNA-binding domain of human papilloma virus E2 protein obtained at high pressure. J. Biol. Chem. 273: 9050-9057.
10. Grant, S.K., Deckman, I.C., Culp, J.S., Minnich, M.D., Brooks, I.S., Hensley, P., Debouck C., and Meek, T.D. 1992. Use of protein unfolding studies to determine the conformational and dimeric stabilities of HIV-1 and SIV proteases. Biochemistry 31: 9491-9501.
11. Gulnik, S.V., Suvorov, L.I., Majer, P., Collins, J., Kane, B.P., Johnson, D.G., and Erickson, J.W. 1997. Design of sensitive fluorogenic substrates for human cathepsin D. FEBS Lett. 413: 379-384.
12. Holzman, T.F., Kohlbrenner, W.E., Weigl, D., Rittenhouse, J., Kempf, D., and Erickson, J. 1991. Inhibitor stabilization of human immunodeficiency virus type-2 proteinase dimer formation. J. Biol. Chem. 266: 19217-19220.
13. Ishima, R., Ghirlando, R., Tozser, J., Gronenborn, A.M., Torchia, D.A., and Louis, J.M. 2001. Folded monomer of HIV-1 protease. J. Biol. Chem. 276: 49110-49116.
14. Jordan, S.P., Zugay, J., Darke, P.L., and Kuo, L.C. 1992. Activity and dimerization of human immunodeficiency virus protease as a function of solvent composition and enzyme concentration. J. Biol. Chem. 267: 20028-20032.
15. Konvalinka, J., Strop, P., Velek, J., Cerna, V., Kostka, V., Phylip, L.H., Richards, A.D., Dunn, B.M., and Kay, J. 1990. Sub-site preferences of the aspartic proteinase from the human immunodeficiency virus, HIV-1. FEBS Lett. 268: 35-38.
16. Konvalinka, J., Bláha, I., Škrabana, R., Sedláček, J., Pichová, I., Kaprálek, F., Kostka, V., and Štrop, P. 1991. Subsite specificity of the proteinase from myeloblastosis associated virus. FEBS Lett. 282: 73-76.
17. Konvalinka, J., Hořejší, M., Andreá nský, M., Novek, P., Pichová, I., Bláha, I., Fábry, M., Sedláček, J., Foundling, S., and Štrop, P. 1992. An engineered retroviral proteinase from myeloblastosis-associated virus acquires pH dependence and substrate specificity of the HIV-1 proteinase. EMBO J. 11: 1141-1144.
18. Konvalinka, J., Litterst, M.A., Welker, R., Kottler, H., Rippmann, F., Heuser, A.M., and Krausslich, H.G. 1995. An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity. J. Virol. 69: 7180-7186.
19. Konvalinka, J., Litera, J., Weber, J., Vondrášek, J., Hradilek, M., Souček, M., Pichová, I., Majer, P., Štrop, P., Sedláček, J., et al. 1997. Configurations of diastereomeric hydroxyethylene isosteres strongly affect biological activities of a series of specific inhibitors of human-immunodeficiency-virus proteinase. Eur. J. Biochem. 250: 559-566.
20. Kräusslich, H.G. 1991. Human immunodeficiency virus proteinase dimer as component of the viral polyprotein prevents particle assembly and viral infectivity. Proc. Natl. Acad. Sci. 88: 3213-3217.
21. Kuzmič, P. 1993. Kinetic assay for HIV proteinase subunit dissociation. Biochem. Biophys. Res. Commun. 191: 998-1003.
22. Louis, J.M., Ishima, R., Nesheiwat, I., Pannell, L.K., Lynch, S.M., Torchia, D.A., and Gronenborn, A.M. 2003. Revisiting monomeric HIV-1 protease: Characterization and redesign for improved properties. J. Biol. Chem. 278: 6085-6092.
23. Majer, P., Urban, J., Gregorova, E., Konvalinka, J., Novek, P., Stehlikova, J., Andreansky, M., Sedlacek, J., and Strop, P. 1993. Specificity mapping of HIV-1 protease by reduced bond inhibitors. Arch. Biochem. Biophys. 304: 1-8.
24. Matayoshi, E.D., Wang, G.T., Krafft, G.A., and Erickson, J. 1990. Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer. Science 247: 954-958.
25. Mohana-Borges, R., Pacheco, A.B., Sousa, F.J., Foguel, D., Almeida, D.F., and Silva, J.L. 2000. LexA repressor forms stable dimers in solution: The role of specific DNA in tightening protein-protein interactions. J. Biol. Chem. 275: 4708-4712.
26. Pargellis, C.A., Morelock, M.M., Graham, E.T., Kinkade, P., Pav, S., Lubbe, K., Lamarre, D., and Anderson, P.C. 1994. Determination of kinetic rate constants for the binding of inhibitors to HIV-1 protease and for the association and dissociation of active homodimer. Biochemistry 33: 12527-12534.
27. Pearl, L. and Blundell, T. 1984. The active site of aspartic proteinases. FEBS Lett. 174: 96-101.
28. Pearl, L.H. and Taylor, W.R. 1987. A structural model for the retroviral proteases. Nature 329: 351-354.
29. Pichová, I., Štrop, P., Sedláček, J., Kaprálek, F., Beneš, V., Trávníček, M., Pavlíčková, L., Souček, M., Kostka, V., and Foundling, S. 1992. Isolation, biochemical characterization and crystallization of the p15gag proteinase of myeloblastosis associated virus expressed in E. coli. Int. J. Biochem 24: 235-242.
30. Ridky, T.W., Bizub-Bender, D., Cameron, C.E., Weber, I.T., Wlodawer, A., Copeland, T., Skalka, A.M., and Leis, J. 1996. Programming the Rous sarcoma virus protease to cleave new substrate sequences. J. Biol. Chem. 271: 10538-10544.
31. Rose, J.R., Babe, L.M., and Craik, C.S. 1995. Defining the level of human immunodeficiency virus type 1 (HIV-1) protease activity required for HIV-1 particle maturation and infectivity. J. Virol. 69: 2751-2758.
32. Schatz, G.W., Reinking, J., Zippin, J., Nicholson, L.K., and Vogt, V.M. 2001. Importance of the N terminus of Rous sarcoma virus protease for structure and enzymatic function. J. Virol. 75: 4761-4770.
33. Silva, J.L., Oliveira, A.C., Gomes, A.M., Lima, L.M., Mohana-Borges, R., Pacheco, A.B., and Foguel, D. 2002. Pressure induces folding intermediates that are crucial for protein-DNA recognition and virus assembly. Biochim. Biophys. Acta 1595: 250-265.
34. Stříšovsky̌, K., Tessmer, U., Langner, J., Konvalinka, J., and Kräusslich, H.G. 2000. Systematic mutational analysis of the active-site threonine of HIV-1 proteinase: Re-thinking the "fireman's grip" hypothesis. Protein Sci. 9: 1631-1641.
35. Suarez, M.C., Lehrer, S.S., and Silva, J.L. 2001. Local heterogeneity in the pressure denaturation of the coiled-coil tropomyosin because of subdomain folding units. Biochemistry 40: 1300-1307.
36. Towler, E.M., Gulnik, S.V., Bhat, T.N., Xie, D., Gustschina, E., Sumpter, T.R., Robertson, N., Jones, C., Sauter, M., Mueller-Lantzsch, N., et al. 1998. Functional characterization of the protease of human endogenous retrovirus, K10: Can it complement HIV-1 protease? Biochemistry 37: 17137-17144.
37. Uhlílcová, T., Konvalinka, J., Pichová, I., Souček, M., Kraüsslich, H.G., and Vondrášek, J. 1996. A modular approach to HIV-1 proteinase inhibitor design. Biochem. Biophys. Res. Commun. 222: 38-43.
38. Wlodawer, A., Miller, M., Jaskolski, M., Sathyanarayana, B.K., Baldwin, E., Weber, I.T., Selk, L.M., Clawson, L., Schneider, J., and Kent, S.B. 1989. Conserved folding in retroviral proteases: Crystal structure of a synthetic HIV-1 protease. Science 245: 616-621.
39. Xie, D., Gulnik, S., Gustchina, E., Yu, B., Shao, W., Qoronfleh, W., Nathan, A., and Erickson, J.W. 1999. Drug resistance mutations can effect dimer stability of HIV-1 protease at neutral pH. Protein Sci. 8: 1702-1707.
40. Zábranský, A. 1999. "Analysis of the protease from Mason-Pfizer monkey retrovirus." PhD thesis, Institute of Organic Chemistry and Biochemistry, Prague, Czech Republic.
41. Zábranský, A., Andreánsky, M., Hruš ková-Heidingsfeldová, O., Havlíček, V., Hunter, E., Ruml, T., and Pichová, I. 1998. Three active forms of aspartic proteinase from Mason-Pfizer monkey virus. Virology 245: 250-256.
42. Zamyatnin, A.A. 1972. Protein volume in solution. Prog. Biophys. Mol. Biol. 24: 107-123.
43. Zhang, Z.Y., Poorman, R.A., Maggiora, L.L., Heinrikson, R.L., and Kezdy, F.J. 1991. Dissociative inhibition of dimeric enzymes: Kinetic characterization of the inhibition of HIV-1 protease by its COOH-terminal tetrapeptide. J. Biol. Chem. 266: 15591-15594.
44. Zybarth, G. and Carter, C. 1995. Domains upstream of the protease (PR) in human immunodeficiency virus type 1 Gag-Pol influence PR autoprocessing. J. Virol. 69: 3878-3884.